Skip to main content

Peer Review reports

From: Budget impact assessment of Aprokam® compared with unlicensed cefuroxime for prophylaxis of post-cataract surgery endophthalmitis

Original Submission
12 Jan 2015 Submitted Original manuscript
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
12 Jun 2015 Editorially accepted
8 Jul 2015 Article published 10.1186/s12886-015-0056-5

You can find further information about peer review here.

Back to article page